Gene-based therapies for a variety of inherited and acquired pulmonary diseases will require the development of vectors capable of safe and efficient transfer of DNA to the respiratory epithelium. The present study examined the feasibility of delivering DNA to respiratory epithelial cells by the receptor-mediated endocytosis pathway. This strategy employs molecular conjugates consisting of a cognate moiety, in this case human transferrin, covalently linked to a DNA-binding moiety, such as a cationic polyamine. Complexes were formed between transferrin-polylysine conjugates (hTfpL) and plasmid DNA carrying the firefly luciferase reporter gene (pRSVL). The conjugate-DNA complexes were added directly to cells in tissue culture and incubated fo...
Thesis (M.Sc.)-University of Durban-Westville, 1986.The correction of human genetic disorders by tra...
Potential problems with the use of viral vectors for gene therapy necessitate the development of eff...
Gene therapy for cystic fibrosis using non-viral, plasmid-based formulations has been the subject of...
Gene-based therapies for a variety of inherited and acquired pulmonary diseases will require the dev...
Gene-based therapies for a variety of inherited and acquired pulmonary diseases will require the dev...
Genes of interest can be targeted specifically to respiratory epithelial cells in intact animals wit...
Most current gene transfer methods function satisfactorily in specialized systems involving establis...
We have developed a high-efficiency nucleic acid delivery system that uses receptor-mediated endocyt...
This chapter describes the methods for preparing and using transferrin-polycation and other ligand-p...
We have developed a high-efficiency nucleic acid delivery system that uses receptor-mediated endocyt...
We have previously described a gene delivery system based upon the receptor-mediated endocytosis of ...
We have subverted a receptor-mediated endocytosis event to transport genes into human leukemic cells...
Association of a targeting ligand such as transferrin, or an endosome disrupting peptide such as GAL...
Efficient gene transfer to the airways by nonviral vectors is a function of different parameters, am...
Adenovirus-polylysine-DNA complexes were evaluated for their capacity to accomplish direct in vivo g...
Thesis (M.Sc.)-University of Durban-Westville, 1986.The correction of human genetic disorders by tra...
Potential problems with the use of viral vectors for gene therapy necessitate the development of eff...
Gene therapy for cystic fibrosis using non-viral, plasmid-based formulations has been the subject of...
Gene-based therapies for a variety of inherited and acquired pulmonary diseases will require the dev...
Gene-based therapies for a variety of inherited and acquired pulmonary diseases will require the dev...
Genes of interest can be targeted specifically to respiratory epithelial cells in intact animals wit...
Most current gene transfer methods function satisfactorily in specialized systems involving establis...
We have developed a high-efficiency nucleic acid delivery system that uses receptor-mediated endocyt...
This chapter describes the methods for preparing and using transferrin-polycation and other ligand-p...
We have developed a high-efficiency nucleic acid delivery system that uses receptor-mediated endocyt...
We have previously described a gene delivery system based upon the receptor-mediated endocytosis of ...
We have subverted a receptor-mediated endocytosis event to transport genes into human leukemic cells...
Association of a targeting ligand such as transferrin, or an endosome disrupting peptide such as GAL...
Efficient gene transfer to the airways by nonviral vectors is a function of different parameters, am...
Adenovirus-polylysine-DNA complexes were evaluated for their capacity to accomplish direct in vivo g...
Thesis (M.Sc.)-University of Durban-Westville, 1986.The correction of human genetic disorders by tra...
Potential problems with the use of viral vectors for gene therapy necessitate the development of eff...
Gene therapy for cystic fibrosis using non-viral, plasmid-based formulations has been the subject of...